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Edited by Ned ManteiAbstract The intermediate ﬁlament protein nestin is expressed
in the neural stem cells of the developing central nervous system
(CNS). Promoter analysis revealed that the minimal promoter of
the mouse nestin gene resides in the region )11 to +183 of the 50-
non-coding and upstream ﬂanking region, and that two adjacent
Sp1-binding sites are necessary for promoter activity. Electro-
phoretic mobility-shift assays (EMSA) and supershift assays
showed that Sp1 and Sp3 proteins selectively bind to the
upstream Sp1 site. These results demonstrate an important
functionality of Sp1 and Sp3 in regulating the expression of the
mouse nestin gene.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Nestin, an intermediate ﬁlament protein, is expressed in the
neural stem cells of the developing central nervous system
(CNS) [1–4]. In situ hybridization demonstrated the presence
of nestin mRNA in the neural tube neuroepithelial and radial
glia cells of mouse embryos at embryonic day 10.5 (E10.5) [5].
The nestin protein was found in the rat neural tube prior to but
not post neurogenesis [6]. Consistent with this observation,
nestin expression exhibits a sharp decline in the motor neurons
of spinal cord and marginal layer neurons of the telencephalon
accompanied by the cessation of mitosis of these cells [5]. From
E15.5 to postnatal day 0, nestin mRNA is expressed pre-
dominantly in the cerebellum, the ventricular and subventric-
ular telencephalon [5], as well as some regions of the adult
brain [7]. Nestin expression is not restricted to the neural stem
cells, as it has also been detected in myogenic precursor cells,
tooth buds, limb buds, the heart, testis, and eyes [8–13].q The nucleotide sequence reported has been submitted to the DDBJ,
EMBL and GenBank Nucleotide Sequence Databases under the ac-
cession number AY331185.
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doi:10.1016/j.febslet.2004.03.097Human, rat and mouse nestin share considerable similarity
in their gene structures [3,14,15]. Studies in transgenic mice
demonstrated that two tissue-speciﬁc enhancers in the ﬁrst and
second introns of the rat nestin gene are required and suﬃcient
to drive reporter gene expression in developing muscle and
neural precursors, respectively [14]. The neural stem cell-spe-
ciﬁc enhancer resides in the 30-region of the second intron
[16,17], and a cis-element for the POU transcription factors is
responsible for nestin expression in the CNS [17]. It has been
shown that nestin is a target gene of thyroid transcription
factor-1 (TTF-1, also known as Nkx2.1), which is involved in
the organogenesis of the forebrain [18]. However, the structure
and function of the nestin gene promoter remained unclear.
Our previous study described the cloning of mouse nestin
gene and the functional expression of its cDNA in COS7 cells
[15,19]. The mouse nestin gene was found to be expressed in the
developing eye and lens [13], and also in the growth cones of
P19 neurons and cerebellar granule cells [20]. In order to un-
derstand the molecular mechanisms of regulation of the nestin
gene expression, we have characterized its promoter. We found
that the proximal promoter is localized to the region between
)11 and +183 of the 50-non-coding and upstream ﬂanking re-
gion, and that two adjacent Sp1-binding sites are required for
the promoter activity. Our results further indicate that Sp1 and
Sp3 proteins selectively bind to the upstream Sp1 site.2. Materials and methods
2.1. RNA puriﬁcation
Poly(A)þ RNA were isolated from embryonic day 15.5 (E15.5)
mouse embryo brain tissues and P19 cells by using the Oligotex
mRNA kit according to the manufacturer’s protocol (Qiagen, Hilden,
Germany).
2.2. Primer extension
An oligonucleotide corresponding to positions +178 to +159 (primer
PE, 50-GCACTAGAGAAGGGAGTGGC-30) of exon 1 was end-la-
belled with [c-32P]ATP using T4 polynucleotide kinase (TaKaRa,
Dalian, China). 2 lg poly(A)þ RNA or 10 lg yeast tRNA was incu-
bated with 2.5 pmol of the labelled oligonucleotide for 15 min at 75 C,
then cooled on ice for 5 min, and mixed with Superscript II reverse
transcriptase (Gibco, Rockville, MD, USA). Elongation was per-
formed for 1 h at 42 C. The primer-extended fragment was analyzed
on a 6% polyacrylamide/7 M urea sequencing gel along with a dideoxy
chain termination sequencing reaction with a genomic clone as tem-
plate and the PE primer as the sequencing primer.
2.3. Cell culture and co-transfection assays
Cell lines including mouse embryonic carcinoma P19 cells,
NIH3T3, CHO, F9, C6, and SY5Y cells were maintained inblished by Elsevier B.V. All rights reserved.
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vine serum (HyClone, Logan, UT, USA) at 37 C in 5% CO2. Cells
were seeded into 24-well plates at a density of 2–4 104 cells/well.
Twenty four hours later, 0.4 lg of ﬁreﬂy luciferase (LUC) reporter
and 0.1 lg of pRL-TK plasmids (Promega, Madison, WI, USA)
containing the Renilla LUC gene downstream of the herpes simplex
virus thymidine kinase (TK) promoter were co-transfected into cells
using LipofectAMINE reagent (Gibco) according to the manufac-
turer’s protocol. After 40 h, cells were washed with phosphate-
buﬀered saline and lysed with passive lysis buﬀer (Promega). Ten
microlitres of the supernatant was analyzed for LUC reporter ac-
tivity on a luminometer by the dual LUC reporter system (Pro-
mega). The transfection eﬃcacy was normalized by Renilla LUC. A
minimum of triplicates of all experiments was carried out and
similar results were obtained.
2.4. Generation of reporter gene constructs
A series of reporter gene constructs was prepared in the pGL3-
Basic vector (Promega) to analyze promoter activity of the 50-up-
stream region of the mouse nestin gene. Two sets of primers (P85F/
P85R and P83F/P85R, Table 1) and the pNX7 plasmid were used to
amplify an 887-bp and a 2660-bp fragment both at the 50-non-
coding and upstream ﬂanking region of the mouse nestin gene. The
fragments were cloned into the pGEM-T-easy vector (Promega) and
the DNA sequences were veriﬁed. These fragments were then sub-
cloned into pGL3-Basic vector to make the reporter gene constructs,
pNESP)704/+183 and pNESP)2477/+183. A 3.2-kb fragment from
the SacI and AatII digestion of plasmid pNX7 was inserted into
pNESP-704/+183 to generate the plasmid pNESP)3809/+183. A
KpnI–SacI polylinker from pBluescript II SK ()) was introduced
into pNESP)3809/+183 to create pNESP(SK))3809/+183. Then,
three 50-deletion constructs were generated through diﬀerent re-
striction enzyme digestion and self-ligation of pNESP(SK))3809/
+183: pNESP)1672/+183 (PstI), pNESP)161/+183 (ApaI) and
pNESP)3007/+183 (EcoRV and PvuII). Similarly, two 30-deletion
constructs were obtained from pNESP)3809/+183: pNESP)3809/
)2155 was created by NcoI digestion and self-ligation;Table 1
Sequences of primers used for construction of plasmids
Primers Sequences
P83F 50-GAGAACGCGTGGCAGGTGGCTCACA
P85F 50-GAGAACGCGTAGAGCCGCGTAACTT
P85R 50-GAGACTCGAGGTGGAGCACTAGAGA
P95F 50-GAGAACGCGTATGAATACCCTCGCT
P95R 50-GAGACTCGAGGTGGAGCACTAGAGA
P114F 50-GAGAACGCGTGGGCTGTGTGTTGCA
P114R 50-GAGACTCGAGGGGTATTCATACTCC
P116F 50-GAGAACGCGTTAGGGACCGCCCCTT
P116R 50-GAGACTCGAGGAGTAGCGGCGACAG
P118BR 50-GAGACTCGAGGGCCTTAACCCTTTA
P119R 50-GAGACTCGAGCCAGCGGAAGCGGAG
P120F 50-GAGACTCGAGGGGCCCAGTTCTGTG
P120R 50-GAGAACGCGTTGGAGCACTAGAGAA
P117AF 50-GAGAACGCGTTGGGGCCCAGTTCTG
P117AR 50-TCATACTgaattCGGCCGGGCGGAA
P117BF 50-CCGGCCGaattcAGTATGAATACCC
P117BR 50-GAGACTCGAGGGAGCACTAGAGAAG
P130AR 50-AGGGTAagatctCTCCCGCCGGCCG
P130BF 50-CGGGAGggatccTACCCTCGCTTCA
P131AR 50-GAAAAGaGatctTCCCTAGGCCTTA
P131BF 50-TAGGGAggatCCCTTTTCCGCCCGG
P132AR 50-GCCGGCgaattcGAAAAGGGGCGGT
P132BF 50-CTTTTCgaattcGCCGGCGGGAGTA
P133AR 50-GCCGGCgaattcGAAAAGGGatccT
Primers P83F, P85F, P85R, P95F, P95R, P114F, P114R, P116F, P116R,
restriction enzyme recognition site for MluI or XhoI for convenient digesti
pNESP AP2 and contain EcoRI sites. Primers P130AR and P130BF wer
respectively. Primers P131AR and P131BF were used for pNESP Sp1(U) a
P132BF were used for pNESP Sp1(D) and contain EcoRI sites. Primer P13
sites. The lowercase letters denote mutated nucleotides.pNESP)3809/)598 was made by digesting with AatII and XhoI,
blunting the ends with mung bean nuclease (Gibco), and then self-
ligating.
To further analyze the promoter of the mouse nestin gene, additional
deletion constructs were prepared. Plasmid pNESP)704/+183 was
digested with MluI and SmaI, end-blunted with Klenow and self-li-
gated to produce pNESP)11/+183. Plasmid pNESP)161/+183 was
digested with XhoI and SmaI, and further processed similarly to make
pNESP)161/)12. Other deletion plasmids were constructed by am-
plifying pNX7 with diﬀerent sets of primers and inserting these PCR
fragments into the pGL3-Basic vector. All these constructs were con-
ﬁrmed by DNA sequencing. The constructs and corresponding primers
are: pNESP+64/+183, P95F/P95R; pNESP)11/+73, P114F/P114R;
pNESP+28/+131, P116F/P116R; pNESP)11/+131, P114F/P116R;
pNESP)11/+112, P114F/P119R; pNESP+28/+138, P116F/P95R;
pNESP)161/+27, P117AF/P118BR and rpNESP)161/+183, P120F/
P120R. The sequences of the primers are listed in Table 1.2.5. Mutagenesis
Site-directed mutagenesis of cis-elements in the nestin promoter re-
gion was performed as described previously [21]. All constructs were
made by using pNX7 as the PCR template and pGL3-Basic digested by
MluI–XhoI as the vector. The AP2 site-mutant pNESP AP2 was con-
structed by subcloning aMluI–EcoRI fragment ampliﬁed by the primer
set P117AF/P117AR and an EcoRI–XhoI fragment ampliﬁed by the
primer set P117BF/P117BR. Similarly, the TATA-like-mutant pNESP
TATA-like, the Sp1(U) site-mutant pNESP Sp1(U) and the Sp1(D)
site-mutant pNESP Sp1(D) were constructed with the primer sets
P117AF/P130AR+P130BF/P117BR, P117AF/P131AR + P131BF/
P117BR, and P117AF/P132AR+P132BF/P117BR, respectively. The
two Sp1 sites-mutant pNESP Sp1(U,D) was constructed by subcloning
anMluI–EcoRI fragment ampliﬁed by the primer set P117AF/P133AR
using pNESP Sp1(D) as the template and a EcoRI–XhoI fragment
ampliﬁed by the primer set of P132BF/P117BR using pNESP)161/+183
as the template. All these constructs were veriﬁed by DNA sequencing.
The sequences of the primers are listed in Table 1.Positions
ACTATCT-30 )2477/)2456
CTTCACT-30 )704/)683
AGGGAGT-30 +162/+183
TCAGCTC-30 +64/+85
AGGGAGT-30 +162/+183
CT-30 )11/+6
CG-30 +57/+73
TT-30 +28/+44
TG-30 +115/+131
GAG-30 +10/+27
GA-30 +96/+112
CA-30 )161/)145
GG-30 +166/+182
T-30 )163/)148
AAG-30 +40/+67
TCGC-30 +49/+77
GG-30 +165/+181
GGC-30 +47/+74
GCTC-30 +57/+85
ACC-30 +18/+45
CCGG-30 +28/+56
CCC-30 +30/+57
TGAA-30 +40/+68
CCC-30 +30/+57
P118BR, P119R, P120F, P120R, P117AF and P117BR introduced a
on of the PCR product. Primers P117AR and P117BF were used for
e used for pNESP TATA-like and contain BglII and BamHI sites,
nd contain BglII and BamHI sites, respectively. Primers P132AR and
3AR was used for pNESP Sp1(U,D) and contains EcoRI and BamHI
Table 2
Sequences of synthetic oligonucleotides used in EMSA
Oligonucleotides Mutations Sequences
Probe Sp1 Wild type 50-GCCTAGGGACCGCCCCTTTTCCGCCCGG-30
Probe Sp1(U)* Sp1(U) 50-GCCTAGGGAagatCCCTTTTCCGCCCGG-30
Probe Sp1(D)* Sp1(D) 50-GCCTAGGGACCGCCCCTTTTCgaattcG-30
Probe Sp1(U,D)* Sp1(U), Sp1(D) 50-GCCTAGGGAggatCCCTTTTCgaattcG-30
Probe AP2, TATA-like Wild type 50-GGCCGGCGGGAGTATGAATACCC-30
Probe SIE Wild type 50-GATCCAGTTCCCGTCAATCGATC-30
For double-stranded oligonucleotides used in EMSA, only the sense strands are shown. Putative binding sites are underlined. The lowercase letters
denote mutated nucleotides.
L. Cheng et al. / FEBS Letters 565 (2004) 195–202 1972.6. Electrophoretic mobility-shift assay (EMSA) and supershift analysis
Nuclear extracts (NE) were prepared from P19 cells and from mouse
postnatal day 5 (P5) cerebella as described previously [22,23]. Nuclear
proteins (3–6 lg) were preincubated with 2 lg poly(dI-dC) poly(dI-dC)
(Amersham/Pharmacia, Uppsala, Sweden) on ice for 30 min in 5
binding buﬀer containing 20% glycerol, 5 mMMgCl2, 2.5 mM EDTA,
2.5mMDTT, 250mMNaCl and50mMTris–HCl (pH7.5). 32P-labelled
DNAprobe was added to the binding reactionmixture and incubated at
25 C for 30 min. Competition experiment was performed by preincu-
bation of a 100-fold molar excess of unlabelled probe together with
nuclear protein. In the case of the supershift assay, the antibodies (1 lg)
against Sp1 (Sp1(PEP2), Santa Cruz Biotechnology, Santa Cruz, CA,
USA), Sp3 (Sp3(D-20), Santa Cruz) and b-tubulin (Sigma, St. Louis,
MO, USA) were added to the reaction mixture before the addition of
labelled probe. Protein–DNA complexes were fractioned on a prerun
non-denaturing, 6% polyacrylamide gel and subjected to electrophoresis
in 0.5TBE buﬀer. Gels were dried and exposed to X-ray ﬁlm with an
intensifying screen at )80 C. Oligonucleotide sequences of probes and
competitors are reported in Table 2.Fig. 1. Determination of transcription initiation sites of the mouse
nestin gene. A, B: Primer extension assays were performed with 2 lg of
poly(A)þ RNA from E15.5 mouse brain (lane ‘‘Brain’’) or from P19
cells (lane ‘‘P19’’), or with 10 lg of yeast tRNA (lane ‘‘tRNA’’) as
negative control by using a 32P-labelled oligonucleotide within exon 1
as described in Section 2. The transcription initiation sites are indicated
by arrows and the numbers on the right denote their corresponding
positions relative to the ﬁrst transcription initiation site.3. Results
3.1. Determination of transcription initiation sites
To map the 50 end(s) of the mouse nestin gene, primer ex-
tension was performed with an anti-sense oligonucleotide (pri-
mer PE) located in exon 1. Three end-points were obtained in
poly(A)þ RNA from E15.5 mouse embryo brain and from P19
cells, but not in tRNA from yeast (Fig. 1A), indicating three
transcription initiation sites of the gene. These three end-points
were aligned with a dideoxy nucleotide sequencing ladder pre-
pared using the same primer (Fig. 1B), indicating that these sites
corresponded to positions of 216, 126 and 110 bp upstream of
the translation start codon (ATG). The most 50-upstream
transcription initiation site was deﬁned as +1, followed by ini-
tiation sites at positions +91 and +107. These results suggest
that mouse nestin mRNA is transcribed from at least three
diﬀerent initiation sites in mouse fetal brain and in P19 cells.
3.2. Promoter analysis of the mouse nestin gene
Mouse embryonic carcinoma P19 cells can be induced by
retinoic acid (RA) to diﬀerentiate into neural cells including
neurons and glial cells [24]. Nestin mRNA and protein could
be detected in non-induced P19 cells. Analogous to its ex-
pression in the neural stem cells in vivo, nestin was up-regu-
lated upon RA induction, and declined along with neural cell
maturation during RA-induced P19 cell neural diﬀerentiation
([20] and Tang, K. and Jing, N. unpublished observation).
Therefore, P19 cells were used as an in vitro system for pro-
moter analysis of the mouse nestin gene.
To identify potential regulatory elements in the 50-ﬂanking
region of the mouse nestin gene, we generated a series ofpromoter-LUC 50-deletion constructs. The longest construct
pNESP)3809/+183 displayed a higher promoter activity in
P19 cells than that of the control plasmid, pGL3-Basic
(Fig. 2A). Deletion constructs pNESP)3007/+183 and
pNESP)2477/+183, however, reduced the promoter activity
by 31% and 42%, respectively. Further deletions to positions
)1672 (pNESP)1672/+183), )704 (pNESP)704/+183), and
)161 (pNESP)161/+183) resulted in a gradual increase in the
promoter activity. The highest promoter activity was observed
in the construct of pNESP)161/+183, suggesting that there are
inhibitory elements in the nestin promoter within the region
)3809 to )161. The 30-truncation deletions from position +183
to )598, pNESP)3809/)598 and to )2155, pNESP)3809/
)2155 completely abolished the promoter activity. All these
results suggest that the isolated 4 kb genomic fragment of the
mouse nestin gene contains a functional promoter and that the
core sequence of the basal promoter is localized in the region
)161 to +183.
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Fig. 2. Functional analysis of the mouse nestin gene promoter. (A) The promoter activity of the mouse nestin gene resides in the region from )161 to
+183. Left panels: schematic representation of the fragments used for generating the diﬀerent deletion constructs tested in transfection experiments.
Right panels: LUC activities obtained after transfection in P19 cells. (B) Reﬁning the functional region in the nestin gene promoter. Left panels:
schematic representation of promoter deletion constructs used for transient transfection. Transcription initiation sites are marked by ﬁlled arrow-
heads and a putative AP1 element is indicated by an open arrowhead. Right panels: LUC activities obtained after transfection in P19 cells.
Transfection and LUC assays were performed as described in Section 2. The LUC activity of each construct was graphed as the fold increases over
that of pGL3-Basic vector. The results are presented as means S.D. Each experiment was repeated at least three times and similar results were
obtained.
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To further characterize the core promoter region, additional
deletion and truncation constructs were generated and trans-
fected into P19 cells (Fig. 2B). The )161/+183 region was ﬁrst
divided into a 30-proximal 194-bp fragment (pNESP)11/+183)
and a 50-proximal 150-bp fragment (pNESP)161/)12). We
found that the downstream 194-bp fragment possessed full
promoter activity, while the upstream 150-bp region had no
promoter activity. When we further divided the )11/+183 re-gion into two overlapping fragments, a 30-proximal 120-bp
fragment (pNESP+64/+183) and a 50-proximal 84-bp fragment
(pNESP)11/+73), the promoter activities of both constructs
decreased to very low levels. Therefore, the region from )11 to
+183 probably possesses the minimal promoter activity. To
test whether any possible element resides in the 50-upstream
region, we extended (pNESP)161/)12) another 38-bp towards
the 30-terminus, from position )12 to position +27
(pNESP)161/+27), which is beyond the ﬁrst initiation site.
L. Cheng et al. / FEBS Letters 565 (2004) 195–202 199However, we still could not detect any activity. These results
suggest that the nestin promoter localizes in the 50-non-coding
region and a few basepairs upstream of the mouse nestin gene.
As the next step, we constructed internal deletions within the
established minimal promoter region (Fig. 2B). An 104-bp
fragment from position +28 to +131 (pNESP+28/+131)
showed a signiﬁcant increase in promoter activity as compared
to that of pNESP+64/+183 and pNESP)11/+73, implying the
importance of potential cis-elements and two downstream
transcription initiation sites (+91, +107) within this region. As
we further extended another 38-bp upstream from position
+28 to give pNESP)11/+131, promoter activity increased by
approximately 60% as compared to that of pNESP+28/+131.
This 38-bp region contains the ﬁrst transcription initiation site.
Additional transcripts starting at this site might account for
the increased promoter activity. However, deletion of 20 bp at
the 30-end to position +112 (pNESP)11/+112), thereby re-
moving an AP1-binding site, only caused a slight decrease of
the promoter activity, suggesting that the AP1-binding site is
not critical for the nestin promoter. The reporter gene ex-
pression was very low if the fragment )161/+183 was in the
reversed orientation (rpNESP)161/+183). As a summary,
these results indicate that the proximal promoter is primarilyFig. 3. Identiﬁcation of the potential cis-elements in the )161/+183 region. (A
coding region )161 to +183 of the mouse nestin gene. The position of the ﬁrs
putative cis-elements are underlined. The three transcription initiation sites
essential to the nestin gene promoter activity. Left panel: schematic represen
experiments. The transcription initiation sites are marked by ﬁlled arrowhead
asterisks indicate that these sites are mutated. Right panels: LUC activities
were performed as described in Section 2. The LUC activity of each construct
results are presented as means S.D. Each experiment was repeated at leastlocalized in the region from )11 to +183, and the AP1-binding
site may not be required for the promoter activity of the mouse
nestin gene.
3.4. Two Sp1-binding sites indispensable for promoter activity
Sequence analysis of the core promoter region )161/+183
revealed several putative cis-elements such as AP1 and AP2-
binding sites, a TATA-like sequence, and two Sp1-binding
sites (Fig. 3A). In order to evaluate the biological signiﬁcance
of these regulatory elements, reporter constructs carrying
mutated sites were generated and transfected into P19 cells. As
shown in Fig. 3B, mutations of the AP2-binding site (pNESP
AP2*) and the TATA-like sequence (pNESP TATA-like*)
exhibited a slight decrease of promoter activity as compared
with that of the wild-type construct (pNESP)161/+183). In
contrast, mutation of the downstream Sp1-binding site
(pNESP Sp1(D)*) resulted in a moderate decrease of promoter
activity to 64%, mutation of the upstream Sp1 site (pNESP
Sp1(U)*) caused a sharp reduction to 27% and mutation of
both Sp1 sites (pNESP Sp1(U,D)*) led to a minimum activity
of 15% as compared to the wild-type. Consistently, the dele-
tion of these two adjacent Sp1 sites from +28 to +64 in exon 1
decreased the reporter activity more than 10-fold (Fig. 2B,) Positions of potential regulatory elements in the 50 ﬂanking and non-
t transcription initiation site is deﬁned as +1. The core sequences of the
are indicated by bent arrows. (B) Two adjacent Sp1-binding sites are
tation of site mutation reporter gene constructs used for transfection
s and the putative cis-elements are indicated by open arrowheads. The
obtained after transfection in P19 cells. Transfection and LUC assays
was graphed as the fold increases over that of pGL3-Basic vector. The
three times and similar results were obtained.
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that these two Sp1-binding sites contribute to the transcrip-
tional activity of the mouse nestin promoter.
3.5. Sp1 and Sp3 binding to the minimal promoter of mouse
nestin gene
To determine the protein-binding activity of the putative cis-
elements in the minimal promoter region, we prepared NE
from P19 cells and performed EMSA experiments. Two shifted
bands were observed with radiolabelled oligonucleotides con-
taining two Sp1 sites (Probe Sp1, position +25/+52, Table 2)
(Fig. 4A, lane 1). The broad band of lower mobility in Fig. 4
was actually composed of two closely spaced Sp1 and Sp3Fig. 4. EMSA of the +25 to +52 region of the mouse nestin gene promoter. (
cells (P19 cells NE) (lanes 1–10). The competition experiments were perform
non-relevant oligonucleotide (SIE) (lane 3), and mutated Sp1 sites oligonucleo
were performed with antibodies against Sp1 protein (Sp1 Ab) (lane 7), Sp3 p
and non-relevant b-tubulin protein (b-tubulin Ab) (lane 10). Note that there a
+52) was incubated with NE from P19 cells (lane 1) and from mouse P5 c
performed with antibodies against Sp1 protein (Sp1 Ab) (lane 3), Sp3 protei
non-relevant b-tubulin protein (b-tubulin Ab) (lane 6). Note that there are th
The NE from P19 cells (P19 cells NE) were incubated with a 32P-labelled olig
(lanes 1–4), the downstream Sp1 site (32P-Sp1(D)*) (lanes 5–8), or both Sp1 si
with antibodies against Sp1 protein (Sp1 Ab) (lanes 2, 6, 10), Sp3 protein (Sp
12). Note that there are gel-shifted bands in lane 5 and supershifted bands icomplexes (see below), and this was resolved with a lower
exposure of the autoradiograph (data not shown). All shifted
bands were successfully competed away with the non-radio-
labelled probe (Fig. 4A, lane 2), but not with an irrelevant
competitor such as Probe SIE (Fig. 4A, lane 3). To further
conﬁrm the protein-binding speciﬁcity of Sp1-binding sites,
three Sp1-mutated oligonucleotides (Probe Sp1(U), Probe
Sp1(D) and Probe Sp1(U,D)) were used as competitors. The
oligonucleotide containing a mutation in the downstream Sp1
site (Probe Sp1(D)) eﬀectively competed with the radiola-
belled probe (Fig. 4A, lane 5), while the oligonucleotides
containing mutations in the upstream (Probe Sp1(U)) or in
both Sp1 sites (Probe Sp1(U,D)) failed to compete (Fig. 4A,A) 32P-labelled Sp1 probe (+25/+52) was incubated with NE from P19
ed with 100-fold excess of wild-type Sp1 oligonucleotide (Sp1) (lane 2),
tides (Sp1(U)*, Sp1(D)*, Sp1(U,D)*) (lanes 4–6). The supershift assays
rotein (Sp3 Ab) (lane 8), Sp1 and Sp3 proteins (Sp1+Sp3 Abs) (lane 9)
re the supershifted bands in lanes 7–9. (B) 32P-labelled Sp1 probe (+25/
erebellum (P5 cerebellum NE) (lanes 2–6). The supershift assays were
n (Sp3 Ab) (lane 4), Sp1 and Sp3 proteins (Sp1+Sp3 Abs) (lane 5) and
e supershifted bands in lanes 3–5. (C) EMSA with mutated Sp1 probes.
onucleotide carrying a mutation in the upstream Sp1 site (32P-Sp1(U)*)
tes (32P-Sp1(U,D)*) (lanes 9–12). The supershift assays were performed
3 Ab) (lanes 3, 7, 11), Sp1 and Sp3 proteins (Sp1+Sp3 Abs) (lanes 4, 8,
n lanes 6–8.
Fig. 5. Promoter activity of the mouse nestin gene in diﬀerent mam-
malian cell lines. The reporter gene constructs, pNESP-3809/+183,
pNESP)161/+183 and pGL3-Promoter, were transfected into P19, F9,
C6, SY5Y, NIH3T3 and CHO cells. The LUC activities were assayed
as described in Section 2, and were graphed as the fold increases over
that of pGL3-Basic vector. The results are presented as meansS.D.
Each experiment was repeated at least three times, and similar results
were obtained.
L. Cheng et al. / FEBS Letters 565 (2004) 195–202 201lanes 4, 6). The radiolabelled Probe AP2, TATA-like (position
+51/+73) containing the AP2-binding site and TATA-like
motif did not form any shifted bands when assayed with nu-
clear proteins from P19 cells (data not shown). These results
suggest that the Sp1 family of transcription factors participate
in binding to the minimal promoter and that the 50-upstream
Sp1-binding site is more important for the binding of nuclear
proteins.
To identify the proteins binding to these Sp1 sites, supershift
assays were performed with antibodies speciﬁc for Sp1 and Sp3
proteins (Fig. 4A, lanes 7–10). The slowest migrating protein–
DNA complex was supershifted by an antibody against Sp1
(Fig. 4A, lane 7), while the two fast migrating bands were
supershifted by the Sp3-speciﬁc antibody (Fig. 4A, lane 8). All
three bands were supershifted when both antibodies were
present (Fig. 4A, lane 9). No supershifted band was observed,
however, when the non-relevant antibody against b-tubulin
was used (Fig. 4A, lane 10). These results indicated that Sp1
and Sp3 proteins bound speciﬁcally to the +25/+52 region
containing two Sp1 sites.
Since the nestin gene is expressed primarily in the neural stem
cells, it is interesting to see whether these Sp1-binding sites are
also involved in the development of CNS. We thus prepared
NE from the mouse cerebellum of postnatal day 5 (P5) when
nestin was expressed [5] and performed EMSA with radiola-
belled Probe Sp1 (Fig. 4B). Three retarded protein–DNA
complexes were also observed in NE of mouse cerebellum at P5
(Fig. 4B, lanes 1, 2). These complexes were supershifted by
adding the antibodies against Sp1 and Sp3 (Fig. 4B, lanes 3–5),
but not with the antibody against b-tubulin (Fig. 4B, lane 6).
Therefore, we conclude that the Sp1 sites in the minimal pro-
moter of the mouse nestin gene might also be occupied in vivo
by the transcription factors Sp1 and Sp3.
3.6. Selective binding of Sp1 and Sp3 proteins to the 50-upstream
Sp1 site
To further distinguish the diﬀerent binding activities be-
tween the two adjacent Sp1-binding sites, radiolabelled oligo-
nucleotides with the single or double mutated Sp1 site(s)
(Probe Sp1(U), Probe Sp1(D), Probe Sp1(U,D)) were used
to perform supershift assays with NE from P19 cells (Fig. 4C).
Only one complex was observed with probes Sp1(U)* or
Sp1(U,D)* (Fig. 4C, lanes 1–4 and 9–12). In contrast, four
complexes were obtained with probe Sp1(D)*. Only the three
complexes unique to Sp1(D)* could be supershifted by the
Sp1- and Sp3-speciﬁc antibodies (Fig. 4C, lanes 5–8). The
complex common to all probes is presumably non-speciﬁc, or
at least does not contain Sp1 or Sp3, since it could not be
supershifted. Overall, these results show that Sp1 and Sp3 can
bind selectively to the more upstream Sp1 binding site.
3.7. The functions of the mouse nestin gene promoter in diﬀerent
cell lines
To examine whether the promoter of the mouse nestin gene
possesses regulatory elements in mediating cell-type speciﬁc
expression, tests were carried out with cell lines of various
origins, such as mouse embryonic carcinoma cell F9, rat gli-
oma C6, Chinese hamster ovary (CHO), mouse ﬁbroblast
NIH3T3, and human neuroblastoma SH-SY5Y (SY5Y). The
reporter gene constructs pNESP)3809/+183 and pNESP)161/
+183 were transfected into these cells, and the simian virus 40
(SV40) promoter driven reporter gene (pGL3-Promoter) wasused as the positive control (Fig. 5). Both pNESP)161/+183
and pNESP)3809/+183 displayed a signiﬁcant level of pro-
moter activity compared with that of the SV40 promoter in
these cell lines. The fact that comparable promoter activities
were observed in diﬀerent cell line suggests that there are no
cell-type speciﬁc elements in the promoter region of the mouse
nestin gene up to position )3809.4. Discussion
In this study, we determined the transcription initiation sites
of the mouse nestin gene. Analysis of its 50-ﬂanking and non-
coding region revealed that the minimal promoter is localized
in the region )11/+183. Two closely spaced Sp1-binding sites
are critical for the expression of the nestin gene. EMSA and
supershift assays showed that the 50-upstream Sp1 site was
selectively occupied by Sp1 and Sp3 proteins from P19 cells
and the P5 mouse cerebellum.
In order to identify regulatory cis-elements of the mouse
nestin gene, a series of deletion constructs from 50-ﬂanking
region up to position )3809 were analyzed. We found that a
construct containing mainly 50-non-coding region of exon 1
()11/+183) demonstrated a full promoter activity, and there-
fore we believe that potential binding sites for Sp1 and other
putative transcription factors in this region are important for
the expression of the nestin gene. Indeed, a signiﬁcant decrease
in reporter gene expression was observed when the sequences
of the two adjacent Sp1 sites were either deleted or mutated
(Figs. 2B and 3). Thus, it is quite likely that these Sp1 con-
sensus sequences contribute greatly to the expression of the
mouse nestin gene.
Gel retardation assays were used to examine the binding
activity of proteins to these Sp1 consensus sequences. Sp1 and
Sp3 proteins from NE of P19 cells and of P5 mouse cerebellum
were found to bind to an oligonucleotide containing these Sp1
sites (Figs. 4A and B). The Sp4 protein, another Sp family
member, could also recognize the GC-box motif (GGGCGG)
202 L. Cheng et al. / FEBS Letters 565 (2004) 195–202with similar aﬃnity as the Sp1 and Sp3 proteins [25]. The
antibodies speciﬁc to Sp1 and Sp3, however, could supershift
all the protein–DNA complexes formed by P19 cell NE. This
result indicates that it is indeed Sp1 and Sp3 proteins that bind
to these Sp1 sites. The competition assays suggested that Sp1
and Sp3 proteins selectively bind to the upstream Sp1 site,
since an oligonucleotide carrying a mutation in the upstream
Sp1 could not interfere with the formation of the shifted bands
(Fig. 4A). This hypothesis was proven by utilizing the Sp1 site-
mutated oligonucleotides as the radiolabelled probes in the
supershift assays (Fig. 4C).
This study showed that the nestin promoter lacks a func-
tional TATA box, that it has three transcription initiation
sites, and that the two Sp1 sites are important for basal tran-
scription activity. The presence of multiple transcription start
sites is characteristic of TATA-less GC-rich promoters, as in
the promoters of the mouse sulfonylurea receptor 1 gene
(SUR1) [26], the human death receptor 5 gene (DR5) [27] and
the endoplasmic reticulum protein, ERp29, gene [28]. More-
over, it has been indicated that selective binding to several
putative Sp1 sites might be a common mechanism for this type
of promoters, by which transcription factors Sp1 and/or Sp3
mediate the transactivation, as in the cases of the human c-kit
gene [29], the transforming growth factor b type I receptor
gene (TGF-bRI) [30], and the nicotinamide adenine dinucle-
otide phosphate cytochrome P-450 oxidoreductase gene [31].
Sp1 and Sp3 proteins are known to be ubiquitous tran-
scription factors and are involved in the transcriptional regu-
lation of various ‘‘house-keeping’’ genes. It has been well
documented that binding of Sp proteins to GC-box motif can
trigger basal gene expression [32]. Results in this study illus-
trated the importance of of the Sp1-binding sites and Sp family
proteins for the basal promoter activity of the mouse nestin
gene. Consistent with this, the nestin gene promoter showed no
cell-type speciﬁcity, and it could function in diﬀerent mam-
malian cell lines (Fig. 5). Questions remain, however, as to how
the nestin gene establishes its tissue speciﬁc expression in
neural stem cells in vivo. A reasonable speculation is that the
speciﬁc CNS expression may be mediated by the tissue-speciﬁc
enhancer in the second intron of the nestin gene [14,16–18].
Similar to the nestin gene promoter, many intermediate ﬁla-
ment gene promoters are also regulated by Sp1 and Sp3 pro-
teins. Activation of the lamin A proximal promoter is
mediated by Sp1 and Sp3 transcription factors, and the func-
tion of Sp3 is more pronounced than that of Sp1 [33]. Sp1 also
controls the expression of a type-III intermediate ﬁlament
protein, peripherin [34]. Moreover, several GC-rich sequences
are located in the promoter of the human vimentin gene, while
the one close to the transcription initiation site is required for
promoter function and gene expression [35].
In general, Sp1 can activate gene expression, whereas Sp3
can both repress and activate transcription. For the activation
of gene expression, Sp family members may form either ho-
modimer or heterodimer complexes with other nuclear pro-
teins [32]. Further studies will be needed to elucidate the
possible interaction(s) between Sp proteins and other tran-
scription factors during the transactivation of the mouse nestin
gene promoter.
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